Weems Alonzo's Form 4 filing
Eli Lilly & Co (LLY) · filed Oct 11, 2022
- Accession no.
- 0000059478-22-000231
- Filed
- Oct 11, 2022
- Trade date
- Oct 10, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $214.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weems AlonzoCIK 0001869672 | Officer (EVP, ERM & CECO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 10, 2022 | Common Stock | SSaleDisposed | −656 | $326.23 | −$214,006.88 | 6,950 | Direct | |
| Oct 10, 2022 | Common Stock | GGiftDisposed | −450 | $0.00 | $0 | 6,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.